Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Emory University
M.D. Anderson Cancer Center
University Health Network, Toronto
Melanoma Institute Australia
NRG Oncology
City of Hope Medical Center
ETOP IBCSG Partners Foundation
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Pittsburgh
Emory University
NRG Oncology
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
Thomas Jefferson University
Providence Health & Services
Karolinska University Hospital
ImmunityBio, Inc.
ImmunityBio, Inc.
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC
Centre hospitalier de l'Université de Montréal (CHUM)
UNICANCER
Albert Einstein College of Medicine
Yale University
Eastern Cooperative Oncology Group
University Hospital, Ghent
California Pacific Medical Center Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Michigan Rogel Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
Yale University
University of California, San Francisco
University Hospital, Ghent
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
EMD Serono
Memorial Sloan Kettering Cancer Center
University Hospital, Lille
SWOG Cancer Research Network